NCPA recently submitted comments to CMS on its Medicaid proposed rule, supporting PBM transparency provisions and asking CMS to provide further regulation. The requested regulation includes a pass-through payment model, where all monies to PBMs such as reimbursements and rebates are passed through to the managed care organization, and PBMs are paid a flat administrative fee.
Form S-1/A Chromocell Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
federalregister.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from federalregister.gov Daily Mail and Mail on Sunday newspapers.
On May 23, 2023, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule entitled Misclassification of Drugs, Program Administration and Program Integrity Updates.
The overall average annual percentage changes in costs for 14 popular rhinology medications outpaced the general annual inflation rate for 5 of 7 years evaluated, according to a study published in Annals of Allergy, Asthma & Immunology.These cost increases may pose barriers to drug adherence among vulnerable populations, Sina J. Torabi, MD, second-year otolaryngology resident, University of